跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MYXREDLIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MYXREDLIN
Authorized
STANDARD
MYXREDLIN
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2fd43ae56048ef60
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
2fd43ae56048ef60
Drug Approval Canada Name
MYXREDLIN
Product Name
MYXREDLIN
Status
Marketed
Status Date
2023-07-28
Original Market Date
2023-07-28
Din
02529602
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription , Schedule D
Ahfs
68:20.08.08
Atc Original
A10AB01 INSULIN (HUMAN)
Atc Name
a 10 ab 01
Aig Number
0152199004
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
INSULIN (HUMAN)
1 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2fd43ae56048ef60
Type
Standard
Back to Health Canada Approvals